Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Patricia R. Robuck, Naga Chalasani et al.|New England Journal of Medicine|2010Cited by 3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Rohit Loomba et al.|The Lancet|2014Cited by 2.2k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver DiseaseArun J. Sanyal, James Tonascia, Mark L. Van Natta et al.|New England Journal of Medicine|2021Cited by 1.1k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2Qing Zhou, Troy R. Torgerson, Dan Yang et al.|New England Journal of Medicine|2014Cited by 889
Immune dysregulation in human subjects with heterozygous germline mutations in <i>CTLA4</i>Hye Sun Kuehn, Gülbû Uzel, Weiming Ouyang et al.|Science|2014Cited by 844